EPHB2 and cancer: The mechanism of the higher expression of EphB2 acting as a predictive factor for QYHJ treatment arose as a result of the upregulation of EphrinB1, which stimulated the EphB2-expressing cells to inhibit cancer cell growth by downregulating the CDK6 expression.